LB Pharmaceuticals Inc (LBRX)

LB Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Net Income	-	-63.1	-6.28
Depreciation & Amortization	-	0.4	0
Share-Based Compensation	-	3.09	0.3
Other Operating Activities	-	6.56	-6.12
Operating Cash Flow	-	-53.05	-12.09
Capital Expenditures	-	-0.77	-0.03
Change in Investments	-	24	-27.99
Investing Cash Flow	-	23.23	-28.01
Share Issuance / Repurchase	-	0.02	0
Debt Issued / Paid	-	0	0.64
Other Financing Activities	-	38.29	33.04
Financing Cash Flow	-	38.32	33.68
Net Cash Flow	-	8.5	-6.43
Free Cash Flow	-	-53.82	-12.12
Free Cash Flow Per Share	-	-5.29	-1.51

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).